Novo Nordisk Investigational Site

Andalusia, Alabama 36420

0 studies enrolling now · 1 studies all time

What they study most

Diabetes, Diabetes Mellitus, Type 2

Studies at this site

• Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus — Completed